Conversely, FOXP3 has been reported to be an important tumour suppressor gene in breast cancer [21–25], gastric adenocarcinoma [26,27], prostate cancer [28], and non-small cell lung cancer [29]. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.